Catalysts for GlaxoSmithKline LLC

ZEJULA (NIRAPARIB TOSYLATE) — FDA approval

ZEJULA (NIRAPARIB TOSYLATE) — FDA approval

ZEJULA (NIRAPARIB TOSYLATE) — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL CD (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL (LAMOTRIGINE) — FDA approval

LAMICTAL ODT (LAMOTRIGINE) — FDA approval

LAMICTAL ODT (LAMOTRIGINE) — FDA approval

OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA approval

BLUJEPA (GEPOTIDACIN MESYLATE) — FDA approval

Aspen Biopharma Labs Pvt., Ltd. recall (Cls II)

WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approval

FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approval

FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approval

WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approval

WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approval

FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approval

OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA approval

ZEJULA (NIRAPARIB TOSYLATE) — FDA approval

WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approval

WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approval

BREXAFEMME (IBREXAFUNGERP CITRATE) — FDA approval

BREXAFEMME (IBREXAFUNGERP CITRATE) — FDA approval

IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approval

VALTREX (VALACYCLOVIR HYDROCHLORIDE) — FDA approval

BREXAFEMME (IBREXAFUNGERP CITRATE) — FDA approval

LAMICTAL XR (LAMOTRIGINE) — FDA approval